Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated.

The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high valuations, and ...

The Healthcare Businesswomen's Association (HBA) successfully convened the second edition of its annual India Leadership Summit (ILS) at The Lalit Hotel, Mumbai. Under the powerful theme "Winning a ...

"By combining precise tumour targeting with an immunotherapy payload, Daiichi Sankyo is exploring a new way to harness the body's own defences to attack cancer," said Ken Takeshita, the Japanese ...

On Monday, 10 November 2025, the healthcare world was abuzz as two pharmaceutical giants, Pfizer and Novo Nordisk, fiercely ...

Companies don’t generally cut prices out of generosity.

The bidding war between Pfizer ( PFE) and Novo Nordisk ( NVO) over obesity drug developer Metsera ( MTSR) finally ended over ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Concerns about the company's future growth are likely keeping investors away.

Disallowance under section 40(a)(ia) and liability under section 201 operated independently, and assessee could not escape TDS liability merely by making a partial disallowance in its ...

By updating the genetic code inside mRNA vaccines every year, scientists can keep population-level immunity aligned with ...

Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...